Radiotherapy for age-related macular degeneration
National Institute for Clinical Excellence
Record ID 32004000220
English
Authors' objectives:
This study aims to assess the current evidence on the safety and efficacy of radiotherapy for age-related macular degeneration.
Authors' recommendations:
Current evidence shows radiotherapy for age-related macular degeneration to have little efficacy. There are also concerns about its safety. It is suitable for use only within good quality research studies approved by a research ethics committee, specifying the dose of radiation used and with explicit patient consent. Publication of safety and efficacy outcomes will be useful in reducing the current uncertainty. The Institute is not undertaking further investigation at present.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
http://www.nice.org.uk/cms/ip/ipcat.aspx?c=56778
Year Published:
2004
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Ophthalmologic Surgical Procedures
- Radiotherapy
- Macular Degeneration
Contact
Organisation Name:
National Institute for Clinical Excellence
Contact Address:
MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.